Ac(1)-Tyr-N(Me)Ala-Asn-Pro-Dap-Leu-Hyp-Trp-Dab-Trp(EtO2H)(EtO2H)-N(Me)Nle-N(Me)Nle-Leu-Cys(1)-Gly-NH2 presents an intricate peptide sequence incorporating methylated residues, unusual amino acids, and heterocyclic features. These elements allow fine-tuned investigations of folding constraints and hydrophobic-ionic balance. The peptide supports exploration of cross-linked structures and multivalent interactions. Researchers apply it in advanced peptide engineering, biosynthetic modeling, and receptor-binding analysis.
CAT No: R2617
CAS No:1629665-96-8
Synonyms/Alias:BMS-986189;SCHEMBL18254824;EX-A9851;HY-P10375;CS-1053031;1629665-96-8;
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.